EP Application Suite




Czechia

(21 MEPs displayed)

Programme implementing Horizon Europe
Committee on Industry, Research and Energy
A8-0410/2018:


Dita
CHARANZOVÁ
 FOR
Martina
DLABAJOVÁ
 FOR
Petr
JEŽEK
 FOR
Jan
KELLER
 FOR
Jaromír
KOHLÍČEK
 FOR
Kateřina
KONEČNÁ
 FOR
Jiří
MAŠTÁLKA
 FOR
Luděk
NIEDERMAYER
 FOR
Jiří
PAYNE
 AGAINST
Pavel
POC
 FOR
Miroslav
POCHE
 FOR (+) . ‒ Last year, the Commission proposed the regulation on the new Framework Programme for Research and Innovation – Horizon Europe. In less than three months, the Commission, the Council and Parliament reached an agreement. The content of the programme, as a result of the deal, perfectly reflects our priorities. Many important issues will be secured, such as the health cluster, culture, security, energy and climate, innovation and job qualifications. That is why I did not hesitate to express my support.Horizon Europe embodies our aspirations and values in many ways. First, it will fight against climate change, one of the most discussed topics nowadays. Second, the programme focuses on the importance of citizens’ quality of life. In this respect, research broad lines will be mainly dedicated to cancer, cardiovascular diseases and precision medicine, in order to improve citizens’ well-being and medical treatments. Finally, part of the programme aims at increasing gender equality, especially in the field of research and innovation, stimulating the integration of the gender dimension. I believe that all of these issues are currently significant and we need to cope with them as soon as possible.
Stanislav
POLČÁK
 FOR
Jiří
POSPÍŠIL
 FOR
Olga
SEHNALOVÁ
 FOR
Pavel
SVOBODA
 FOR
Pavel
TELIČKA
 FOR (+) . ‒ The Horizon Europe programme (the framework programme) is to be implemented through specific programmes. I voted in favour of the proposed decision, because it sets out detailed rules for implementing Horizon Europe, fixes its duration and provides for the means deemed necessary. I voted in favour as Horizon 2020 is the biggest EU research and innovation programme ever, with nearly EUR 80 billion of funding available over seven years (2014 to 2020) – in addition to the private investment that this money will attract. It promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market.
Evžen
TOŠENOVSKÝ
 FOR
Jan
ZAHRADIL
 FOR
Tomáš
ZDECHOVSKÝ
 FOR
Michaela
ŠOJDROVÁ
 FOR
Jaromír
ŠTĚTINA
(none)